Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Found 11 COAs referencing this lot from 1 vendor.
Aggregated across 11 COAs for this batch
Tested by: Vanguard Laboratory
| Vendor | Peptide | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| Peptidology | TB-500 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | — | |
| Peptidology | DSIP | Vanguard Laboratory | 99.09% | LAL |
| — |
| Peptidology | Tesamorelin/CJC-1295/Ipamorelin | Vanguard Laboratory | 99.50% | LALUSP<71>HM | — |
| Peptidology | GLP3-R | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-03-31 |
| Peptidology | GLP2-T | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-03-25 |
| Peptidology | GHK-Cu | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-03-20 |
| Peptidology | KPV | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-03-16 |
| Peptidology | BPC-157/TB-500 | Vanguard Laboratory | 99.50% | LALUSP<71>HM | 2026-03-16 |
| Peptidology | MOTS-C | Vanguard Laboratory | 99.09% | LALUSP<71>HM | 2026-03-16 |
| Peptidology | GHRP-2 | Vanguard Laboratory | 99.03% | LALUSP<71>HM | 2026-03-16 |
| Peptidology | CJC-1295 no DAC/Ipamorelin | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-02-09 |